Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2 for Immediate Dental Implant Placement
NCT07240493Completed
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of dibotermin alfa in tooth loss and Alveolar ridge resorption (2 arms). Primary endpoint: Implant Stability Quotient at 16 weeks. Started Dec 2024; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
tooth lossAlveolar ridge resorption
Beyond the preview
Go deeper on NCT07240493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240493.